Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Paulweber

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|February 1, 1989
Indirect immunofluorescence test and enzyme-linked immunosorbent assay for detection of Campylobacter pyloriE Schaber, F Umlauft, G Stöffler, et al.
The Journal of Clinical Investigation|August 1, 1987
Lipoprotein binding to cultured human hepatoma cellsF Krempler, G M Kostner, W Friedl, et al.
Atherosclerosis|June 5, 2004
The role of the A54T polymorphism of the intestinal fatty acid binding protein for lipid levels, insulin sensitivity and carotid atherosclerosisW Renner, H Pressl, T C Wascher, et al.
Diabetologia|March 27, 2002
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiencyB Hölzl, B Iglseder, A Sandhofer, et al.
The Journal of Biological Chemistry|September 15, 1992
Nuclease-hypersensitive sites define a region with enhancer activity in the third intron of the human apolipoprotein B geneB Levy-Wilson, B Paulweber, B P Nagy, et al.
Molecular Cell Biology Research Communications : MCBRC|June 21, 2001
An open chromatin structure in a liver-specific enhancer that confers high level expression to human apolipoprotein b transgenes in miceB Levy-Wilson, B Paulweber, T J Antes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factorsF Krempler, D Breban, H Oberkofler, et al.
International Journal of Obesity (2005)|December 13, 2006
The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian populationT K Felder, H Oberkofler, R Weitgasser, et al.
Journal of Lipid Research|April 29, 2000
Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23B Hölzl, H G Kraft, H Wiebusch, et al.
The Journal of Clinical Investigation|February 1, 1993
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalitiesG Miesenböck, B Hölzl, B Föger, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|February 1, 1989
Indirect immunofluorescence test and enzyme-linked immunosorbent assay for detection of Campylobacter pyloriE Schaber, F Umlauft, G Stöffler, et al.
The Journal of Clinical Investigation|August 1, 1987
Lipoprotein binding to cultured human hepatoma cellsF Krempler, G M Kostner, W Friedl, et al.
Atherosclerosis|June 5, 2004
The role of the A54T polymorphism of the intestinal fatty acid binding protein for lipid levels, insulin sensitivity and carotid atherosclerosisW Renner, H Pressl, T C Wascher, et al.
Diabetologia|March 27, 2002
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiencyB Hölzl, B Iglseder, A Sandhofer, et al.
The Journal of Biological Chemistry|September 15, 1992
Nuclease-hypersensitive sites define a region with enhancer activity in the third intron of the human apolipoprotein B geneB Levy-Wilson, B Paulweber, B P Nagy, et al.
Molecular Cell Biology Research Communications : MCBRC|June 21, 2001
An open chromatin structure in a liver-specific enhancer that confers high level expression to human apolipoprotein b transgenes in miceB Levy-Wilson, B Paulweber, T J Antes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factorsF Krempler, D Breban, H Oberkofler, et al.
International Journal of Obesity (2005)|December 13, 2006
The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian populationT K Felder, H Oberkofler, R Weitgasser, et al.
Journal of Lipid Research|April 29, 2000
Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23B Hölzl, H G Kraft, H Wiebusch, et al.
The Journal of Clinical Investigation|February 1, 1993
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalitiesG Miesenböck, B Hölzl, B Föger, et al.
Pageof 6